Short Interest in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Drops By 16.0%

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) was the target of a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 13,100 shares, a drop of 16.0% from the March 31st total of 15,600 shares. Based on an average daily trading volume, of 16,600 shares, the days-to-cover ratio is currently 0.8 days.

Reviva Pharmaceuticals Stock Down 12.6 %

RVPHW stock traded down $0.06 on Tuesday, reaching $0.45. 11,701 shares of the company traded hands, compared to its average volume of 16,830. Reviva Pharmaceuticals has a one year low of $0.40 and a one year high of $3.00. The firm has a fifty day simple moving average of $0.65 and a 200-day simple moving average of $0.95.

Reviva Pharmaceuticals Company Profile

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.